CRLX101 Plus Bevacizumab in Advanced RCC

计划入组 22 人 · 首次发布于 2012 年 6 月 22 日

Pharma-Pen (Formerly Innoject) Auto-injectory TIV

首次发布于 2006 年 6 月 12 日

Bioequivalence Study of Vildagliptin From Gliptus 50 mg Tablet (EVA Pharma, Egypt) and Galvus 50 mg Tablet (NOVARTIS PHARMA, GERMANY)

计划入组 24 人 · 首次发布于 2016 年 6 月 29 日

CRLX-701

Anticancer RNAi therapeutics(Cerulean Pharma)

Thalidomide inhalation (Vicore Pharma)

Bioprojet Pharma

Belgium

ACASTI PHARMA INC

United States

Innate Pharma, Inc.

United States

Elicio Therapeutics Appoints Marc Wolfgang as CTO to Strengthen Commercial Readiness for KRAS-Targeted Cancer Immunotherapy

Royalty Pharma and Zealand Pharma enter $100 million rusfertide funding agreement

FDA Approves Verona Pharma's Ohtuvayre (ensifentrine) for COPD Maintenance